• Home
  • Search Results
  • Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics.

Biodegradable hollow manganese/cobalt oxide nanoparticles for tumor theranostics.

Nanoscale (2019-11-28)
Qilong Ren, Kuikun Yang, Rujia Zou, Zhiping Wan, Zheyu Shen, Guangyu Wu, Zijian Zhou, Qianqian Ni, Wenpei Fan, Junqing Hu, Yijing Liu

This article describes the fabrication of hollow manganese/cobalt oxide nanoparticles (MCO NPs) with a tunable size through a redox reaction and the Kirkendall effect for cancer imaging and drug delivery. MCO-70 NPs (with an average size of 70 nm) can act as glutathione (GSH)-responsive contrast agents for dual T1/T2-weighted magnetic resonance imaging (MRI). The degradation of MCO NPs by GSH led to the enhancement of their T1 and T2 signals by 2.24- and 3.43-fold compared with those of MCO NPs before degradation, respectively. Antitumor agents such as doxorubicin (Dox) could be encapsulated inside the cavity of the hollow MCO NPs (MCO-70-Dox) and be released in the presence of GSH. The MCO-70-Dox NPs showed good tumor growth inhibition effects in vitro and in vivo, and can be promising drug delivery vehicles and MRI contrast agents for tumor diagnosis and reporting drug release.

Product Number
Product Description

Cobalt(II) chloride hydrate, 99.999% trace metals basis

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.